clotrimazole has been researched along with piperidines in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Kendall, DA; Randall, MD | 1 |
Baker, PN; Dunn, WR; Kendall, DA; Kenny, LC; Randall, MD | 1 |
Chen, J; Fu, CY; Han, M; Long, Y; Tian, XZ; Wang, R | 1 |
Charvet, C; Mast, N; Pikuleva, IA; Stout, CD | 1 |
Adami, V; Anelli, V; Gatto, P; Mione, MC; Pancher, M; Precazzini, F; Tushe, A | 1 |
5 other study(ies) available for clotrimazole and piperidines
Article | Year |
---|---|
Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation.
Topics: Animals; Arachidonic Acids; Biological Factors; Bradykinin; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cannabinoids; Clotrimazole; Coronary Vessels; Endocannabinoids; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Piperidines; Polyunsaturated Alkamides; Potassium Channel Blockers; Pyrazoles; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vasodilation | 1997 |
The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arteries; Biological Factors; Bradykinin; Cannabinoids; Carbenoxolone; Clotrimazole; Cyclooxygenase Inhibitors; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Gap Junctions; Glycyrrhetinic Acid; Humans; In Vitro Techniques; Indomethacin; Myometrium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Piperidines; Pregnancy; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vasoconstrictor Agents; Vasodilation | 2002 |
Mechanisms of relaxing response induced by rat/mouse hemokinin-1 in porcine coronary arteries: roles of potassium ion and nitric oxide.
Topics: Animals; Anti-Infective Agents, Local; Clotrimazole; Coronary Vessels; Dequalinium; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Mice; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Nitric Oxide; Nitroarginine; Oxadiazoles; Piperidines; Potassium; Potassium Channel Blockers; Protein Precursors; Quinoxalines; Quinuclidines; Rats; Receptors, Neurokinin-1; Receptors, Prostaglandin; Substance P; Swine; Tachykinins; Tetraethylammonium; Vasodilation | 2007 |
Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.
Topics: Amino Acid Substitution; Anticonvulsants; Antidepressive Agents; Antifungal Agents; Brain; Catalytic Domain; Cholesterol; Cholesterol 24-Hydroxylase; Clotrimazole; Crystallography, X-Ray; Humans; Mutation, Missense; Piperidines; Protein Binding; Pyrimidines; Steroid Hydroxylases; Structure-Activity Relationship; Tranylcypromine; Triazoles; Voriconazole | 2010 |
Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model.
Topics: Animals; Animals, Genetically Modified; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clotrimazole; Disease Models, Animal; Drug Screening Assays, Antitumor; Farnesyltranstransferase; Humans; Melanocytes; Melanoma; Melanoma, Cutaneous Malignant; Miconazole; Piperidines; Pyridines; Skin Neoplasms; Zebrafish | 2020 |